Valuation : Imagion Biosystems Limited

Market Cap 4.32M 3.1M 2.67M 2.53M 2.29M 4.3M 296M 30.02M 11.54M 151M 11.63M 11.38M 476M P/E 2024
-0.5x
P/E 2025 -1.61x
Enterprise Value 5.16M 3.7M 3.19M 3.02M 2.74M 5.14M 354M 35.89M 13.8M 180M 13.91M 13.61M 569M EV / Sales 2024
1.8x
EV / Sales 2025 178x
Free-Float
79.18%
Yield 2024 *
-
Yield 2025 -
1 month-33.33%
3 months-50.00%
6 months-61.90%
Current year-68.00%
1 week 0.01
Extreme 0.008
0.01
1 month 0.01
Extreme 0.007
0.01
Current year 0.01
Extreme 0.007
0.04
1 year 0.01
Extreme 0.007
0.06
3 years 0.01
Extreme 0.007
0.72
5 years 0.01
Extreme 0.007
4.2
10 years 0.01
Extreme 0.007
9
Manager TitleAgeSince
Chief Operating Officer - 2021-10-31
Corporate Secretary 53 2024-05-12
Corporate Officer/Principal - 2024-05-31
Director TitleAgeSince
Chairman 68 2016-12-05
Director/Board Member 53 2024-07-30
Director/Board Member 55 2024-06-13
Date Insider Type Main position Quantity % Market Cap. Importance
8/23/24 Free

Chairman

2,000,000 5.7148%
4/26/23 Buy

Director

32,500 -
4/26/23 Buy 68,125 -
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-74.19%-98.57% 3.1M
+5.65%-2.16%+255.37%+42.62% 3.9B
-0.12%-0.33%+79.39%+288.44% 3.86B
-2.76%-3.90%+28.28%+61.61% 3.29B
+0.48%-1.22%+271.47%+503.36% 2.6B
-1.24%-2.69%-30.86%-32.66% 2.05B
-6.10%-9.32%+40.19% - 1.54B
+0.16%-1.10%+23.73%+38.38% 1.07B
-2.97%-10.79%+134.05%-37.33% 971M
-1.13%+0.73%-0.52%+49.53% 616M
Average -0.80%-3.85%+72.69%+90.60% 1.99B
Weighted average by Cap. -0.08%-3.21%+113.25%+150.30%

Financials

2024 2025
Net sales 2.67M 1.91M 1.65M 1.56M 1.41M 2.65M 183M 18.52M 7.12M 92.9M 7.18M 7.02M 294M 73.03K 52.38K 45.13K 42.73K 38.73K 72.66K 5M 508K 195K 2.55M 197K 192K 8.04M
Net income -2.07M -1.48M -1.28M -1.21M -1.1M -2.06M -142M -14.36M -5.52M -72.05M -5.57M -5.45M -228M -4.31M -3.09M -2.66M -2.52M -2.29M -4.29M -295M -29.95M -11.52M -150M -11.61M -11.35M -475M
Net Debt 177K 127K 109K 103K 93.76K 176K 12.11M 1.23M 472K 6.16M 476K 466K 19.47M 845K 606K 522K 494K 448K 841K 57.89M 5.87M 2.26M 29.45M 2.28M 2.23M 93.06M
Logo Imagion Biosystems Limited
Imagion Biosystems Limited is a medical imaging company. The Company is developing a non-radioactive and precision diagnostic molecular imaging technology. Its principal activity consists of nanotechnology, biotechnology, cancer diagnostics and medical imaging using magnetic resonance. It uses bio-safe magnetic nanoparticles to detect cancer and other diseases. The Company operates through Research and Development segment. Its MagSense HER2 Imaging Agent (MSH2IA) is a first-in-class molecular imaging product candidate that is intended to detect tumors more accurately than relying solely on anatomical abnormalities seen in conventional imaging. With its tumor targeting, MSH2IA produces Magnetic resonance imaging (MRI) images that are differentiable between an abnormal lymph node and a normal node in HER2 positive breast cancer patients undergoing axillary imaging. Its PrecisionMRX products include Dextran-Coated, mPEG Coated, Oleic Acid Coated and Carboxylic Acid Functionalized.
Employees
-
Date Price Change Volume
26-09-11 A$0.008000 0.00% 2,979,293
26-09-10 A$0.008000 0.00% 1,060,697
26-09-09 A$0.008000 -5.88% 5,447,265
26-09-08 A$0.008500 +6.25% 146,111
26-09-07 A$0.008000 0.00% 147,028
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!